Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-02

Clinical Trial Update: Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)

View source ↗

Summary

Completed clinical trial evaluating a two-drug regimen of raltegravir and darunavir (BIRDi) for HIV/AIDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isentress (Raltegravir)
  • PREZISTA (darunavir)

Snippet

Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas | Conditions: Comorbidities, HIV/AIDS | Status: COMPLETED